Cardiac marker

(Redirected from Cardiac enzymes)
Jump to navigation Jump to search
Kinetics of cardiac markers in myocardial infarction with or without reperfusion treatment.

Template:DiseaseDisorder infobox

WikiDoc Resources for Cardiac marker


Most recent articles on Cardiac marker

Most cited articles on Cardiac marker

Review articles on Cardiac marker

Articles on Cardiac marker in N Eng J Med, Lancet, BMJ


Powerpoint slides on Cardiac marker

Images of Cardiac marker

Photos of Cardiac marker

Podcasts & MP3s on Cardiac marker

Videos on Cardiac marker

Evidence Based Medicine

Cochrane Collaboration on Cardiac marker

Bandolier on Cardiac marker

TRIP on Cardiac marker

Clinical Trials

Ongoing Trials on Cardiac marker at Clinical

Trial results on Cardiac marker

Clinical Trials on Cardiac marker at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cardiac marker

NICE Guidance on Cardiac marker


FDA on Cardiac marker

CDC on Cardiac marker


Books on Cardiac marker


Cardiac marker in the news

Be alerted to news on Cardiac marker

News trends on Cardiac marker


Blogs on Cardiac marker


Definitions of Cardiac marker

Patient Resources / Community

Patient resources on Cardiac marker

Discussion groups on Cardiac marker

Patient Handouts on Cardiac marker

Directions to Hospitals Treating Cardiac marker

Risk calculators and risk factors for Cardiac marker

Healthcare Provider Resources

Symptoms of Cardiac marker

Causes & Risk Factors for Cardiac marker

Diagnostic studies for Cardiac marker

Treatment of Cardiac marker

Continuing Medical Education (CME)

CME Programs on Cardiac marker


Cardiac marker en Espanol

Cardiac marker en Francais


Cardiac marker in the Marketplace

Patents on Cardiac marker

Experimental / Informatics

List of terms related to Cardiac marker

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Medical tests that are often referred to as cardiac markers include:

Cardiac markers are substances released from heart muscle when it is damaged as a result of myocardial infarction. Depending on the marker, it can take between 2 to 24 hours for the level to increase in the blood. Additionally, determining the levels of cardiac markers in the laboratory - like many other lab measurements - takes substantial time. Cardiac markers are therefore not useful in diagnosing a myocardial infarction in the acute phase. The clinical presentation and results from an ECG are more appropriate in the acute situation.

See Also

Ischemia-Modified Albumin (IMA) can be detected via the albumin cobalt binding (ACB) test, a limited available FDA approved assay. Myocardial ischemia alters the N-terminus of albumin reducing the ability of cobalt to bind to albumin. IMA measures ischemia in the blood vessels and thus returns results in minutes rather than traditional markers of necrosis that take hours. ACB has low specificity therefore generating high number of false positives and must be used in conjunction with typical acute approaches such as ECG and physical exam. Additional studies are required.

Further reading

  • Ross G, Bever F, Uddin Z, Devireddy L, Gardin J (2004). "Common scenarios to clarify the interpretation of cardiac markers". J Am Osteopath Assoc. 104 (4): 165–76. PMID 15127984.Full text

External Links

Template:Abnormal clinical and laboratory findings

Template:WikiDoc Sources Cardiology